# Smiths Medical receives $20M federal funding for syringe production expansion

Smiths Medical partnered with BARDA and the DoD to expand capacity at its Keene, N.H. facility for hypodermic needle and syringe production. BARDA will invest $20 million into a $38 million capital expansion project, and Smiths Medical received an order for 78.6 million syringe and needle units.

- Type: Contract
- Announced: 2020-07-16
- Where: Keene, N.H., United States
- Value: $20.0M
- Status: announced
- Capacity: 125 million units per year
- Products: hypodermic needles, syringes
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Smiths Medical](https://endata.com/companies/46970.md)
- [Biomedical Advanced Research and Development Authority](https://endata.com/companies/8807.md) (customer)
- [Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense](https://endata.com/companies/48609.md) (customer)

## Sources

- [medicalbuyer.co.in](https://medicalbuyer.co.in/smiths-medical-receives-20m-federal-funding-for-covid-19-vaccine-efforts/), 2020-07-16: "Smiths Medical has received an order through our authorized distributor Marathon Medical’s BARDA IDIQ agreement for 78.6 million syringe and needle units."
- [nhbr.com](https://www.nhbr.com/keene-medical-device-facilitys-parent-company-wins-big-vaccine-related-contract/), 2020-07-16: "Smiths Medical, which is based in Plymouth, Minn., said it has entered into an agreement with the Biomedical Advanced Research and Development Authority at the Department of Health and Human Services and the Department of Defense’s Joint Program Executive Office for Chemical, Biological, Radiologica"

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.